Sign inJoin waitlistJoin the waitlist

AR

Angela Ricci

Section Chief · Geisel School of Medicine

Credentials: · · ·

History

Geisel School of Medicine
Present
Geisel School of Medicine
Present

Pediatrics
Children's Hospital At Dartmouth
2012–2015
Columbia Univ Coll of Phys & Surgeons
2008–2012
Princeton University

Research

T cell depletion utilizing CD34(+) stem cell selection and CD3(+) addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients
British Journal of Haematology · 2012 · 29 citations
A comparison of bronchoalveolar lavage versus lung biopsy in pediatric recipients after stem cell transplantation
Biology of Blood and Marrow Transplantation · 2014 · 27 citations
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab…
Biology of Blood and Marrow Transplantation · 2016 · 22 citations

Monica Bhatia
6 papers
Prakash Satwani
6 papers
Diane George
5 papers
James Garvin
5 papers
Mitchell Cairo
4 papers
Bachir Alobeid
2 papers
Jenny Ruiz
2 papers · 2 as a resident
Larisa Broglie
2 papers · 2 as a fellow
MG
Mark Geyer
2 papers · 2 as a resident
Raymond Walston
2 papers · 2 as a fellow
WB
Wallace Bourgeois
2 papers · 1 as a fellow
AM
Alison Marshall
1 paper

Clinical trials

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2033